Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulin

By sjmartinez • June 28, 2023

Bae SS, Faure-Kumar E, Ferbas K, Wang J, Shahbazian A, Truong L, Yang H, McMahon M, FitzGerald JD, Charles-Schoeman C. Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulin. Rheumatol Int. 2023 Jun 27. doi: 10.1007/s00296-023-05350-1. Epub ahead of print. PMID: 37368037.

Tags: Anti-SARS-CoV2 antibodies, Dermatomyositis, Digestive Diseases, Idiopathic inflammatory myopathies, Intravenous immunoglobulin, Polymyositis, Publications, Rheumatology

Trypsin in pancreatitis: The culprit, a mediator, or epiphenomenon?

Gukovskaya AS, Lerch MM, Mayerle J, Sendler M, Ji B, Saluja AK, Gorelick FS, Gukovsky I. Trypsin in pancreatitis: The culprit, a mediator, or epiphenomenon?[...]

Stricturing Crohn’s Disease: When Biologics May Help or Not?

Fansiwala K, Limketkai BN. Stricturing Crohn's Disease: When Biologics May Help or Not? Inflamm Bowel Dis. 2024 Nov 12:izae264. doi: 10.1093/ibd/izae264. Epub ahead of print.[...]

VPS4A is the selective receptor for lipophagy in mice and humans

Das D, Sharma M, Gahlot D, Nia SS, Gain C, Mecklenburg M, Zhou ZH, Bourdenx M, Thukral L, Martinez-Lopez N, Singh R. VPS4A is the[...]